Table 5.
Statistic of molecular marker | Clinicopathologic factors (p-value only) | |||||
---|---|---|---|---|---|---|
Molecular marker | RR | CI | p-Value | Sex | Age (≥45 years) | Size (>2 cm) |
BRAFV600E | 1.50 | 0.93–2.40 | 0.09 | 0.32 | 0.61 | 0.02* |
miR-21 | 1.02 | 0.90–1.15 | 0.80 | 0.42 | 0.95 | 0.01* |
miR-146-3p | 1.09 | 1.00–1.19 | 0.06 | 0.69 | 0.70 | 0.01* |
miR-146-5p | 1.17 | 1.05–1.32 | 0.01* | 0.56 | 0.41 | 0.02* |
miR-204 | 0.92 | 0.84–1.01 | 0.08 | 0.42 | 0.61 | 0.04* |
miR-221 | 1.10 | 1.01–1.19 | 0.03* | 0.44 | 0.36 | 0.03* |
miR-222 | 1.20 | 1.06–1.36 | 0.00* | 0.28 | 0.50 | 0.02* |
miR-375 | 1.06 | 0.99–1.14 | 0.09 | 0.33 | 0.76 | <0.01* |
Formula: CLNM = molecular marker + sex + age (>45 years) + size (>2 cm).
Each row represents an independent preoperative predictor model performed for CLNM. In the CVPTC prophylactic subgroup, independent preoperative predictors for CLNM were miR-146-5p, miR-221, miR-222, and tumor size.
Statistically significant.